Uscom Balance Sheet Health

Financial Health criteria checks 6/6

Uscom has a total shareholder equity of A$3.1M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$5.1M and A$2.1M respectively.

Key information

Debt to equity ratio

AU$0

Debt

Interest coverage ratio	n/a
Cash	AU$2.52m
Equity	AU$3.06m
Total liabilities	AU$2.07m
Total assets	AU$5.13m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: UCM's short term assets (A$3.9M) exceed its short term liabilities (A$1.3M).

Long Term Liabilities: UCM's short term assets (A$3.9M) exceed its long term liabilities (A$795.0K).

Debt to Equity History and Analysis

Debt Level: UCM is debt free.

Reducing Debt: UCM had no debt 5 years ago.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: UCM has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: UCM has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 2.7% each year.

Uscom Balance Sheet Health

Financial Health criteria checks 6/6

Key information

Recent financial health updates

Uscom Limited to Be Deleted from Other OTC

Recent updates

Less than half of directors are independent

Uscom Limited, Annual General Meeting, Oct 25, 2024

New minor risk - Financial data availability

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited has filed a Follow-on Equity Offering in the amount of AUD 2.014212 million.

Uscom Limited, Annual General Meeting, Oct 26, 2023

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited (ASX:UCM) announces an Equity Buyback for 19,676,833 shares, representing 9.91% for AUD 1.08 million.

Less than half of directors are independent

First half 2023 earnings released: AU$0.008 loss per share (vs AU$0.006 loss in 1H 2022)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited, Annual General Meeting, Nov 10, 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited to Be Deleted from Other OTC

Less than half of directors are independent

Uscom Limited Releases Details of A Study Confirming the High Accuracy of the Uscom BP+ Central Blood Pressure Monitor

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2020)

Uscom Limited Announces Five New Software Copyrights for BP Plus in China

Founder recently bought AU$102k worth of stock

Non-Executive Director recently bought AU$145k worth of stock

Uscom Limited Announces Two New USCOM Monitors Get Australian Tga Clearance

Uscom Limited Announces SpiroSonic Air Approved for European Ce Mark

Uscom Limited Announces Two New Uscom Devices for China

First half 2021 earnings released: AU$0.002 loss per share (vs AU$0.011 loss in 1H 2020)

Uscom Limited Appoints MedCaT as New European Distributor

Uscom Limited announced that it has received funding

Full year earnings released - AU$0.009 loss per share

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Cash Runway Analysis

Discover healthy companies